Tel: +91 124 2821030
Email: info@windlasbiotech.com
Home
About
Our Heritage
EXPERTISE
Our Mission & Vision
Services
Products
Our Brands
Investor Relations
Financial Information
Annual Financials
Quarterly Results
Investor Presentation
Quarterly Results Press Release
Earnings Call Transcript
Audio Transcript
Earnings Conference Call Transcript
Annual Report
Buy Back of Shares
Public Announcement
Daily Reporting
Extinguishment of Shares
Corporate Governance
Committee Composition
List of Directors
Independent Directors
Management Team Information
Code of Conduct
Policies
Annual Return
Credit Rating
Investor Information
Company Fact Sheet
Share Holding Pattern
Stock Prices
Unclaimed dividend
Corporate Announcement
Notice of Board Meeting
Stock Exchange Communication
Monitoring Agency
Statement of Deviation
Secretarial Compliance Report
Schedule of Analyst
Published in Newspaper
Investor Contact
Compliance Officer
Investor Relations
Registrar
Grievance Officer
Contact For Material Event
CSR
Career
Contact
X
Contact us
Stock Exchange Communication
Stock Exchange Communication
FY 24-25
FY 23-24
FY 22-23
FY 21-22
Regulation 74(5) March 31, 2024
Reg 7(3) March 31, 2024
Press Release 02042024
Trading Window 28 March 2024
Audio Transcript Q3 FY 24
Reconciliation of Share Capital Q3 24
As Certificate under Regulation 74(5) for Q3 FY24.
Trading Window Closure 31-12-2023
Recording of Conference Call
Reconciliation of Share Capital Q2 FY 24.
As Certificate under Regulation 74 (5) for Q2 FY 24.
Closure of Trading Window September 30, 2023
Con call for Financial Performance – January 29,2022.
Invite for Investor Meeting September 9, 2021.
Closure of Trading Window September 30, 2021.
Certificate under Reg 74(5)
Reg 74(5) announcement 10 April 2023
Outcome of 22nd AGM held as on September 12, 2023.
Annual Report for FY 2022-23.
22nd AGM Notice
Intimation of Book Closure August 16, 2023
Intimation of Investor Call on Unaudited Financial Results for Q1 FY 24, August 09, 2023”.
Board Meeting Intimation – August 8, 2023
Intimation of Schedule of Analyst & Institutional Investor meeting- July 12, 2023
Intimation of Schedule of Analyst & Institutional Investor meeting- July 11, 2023
Intimation of Schedule of Analyst & Institutional Investor meeting- July 7, 2023
Closure of Trading Window June 30, 2023
June 17th 2023- Clarification to stock Exchange for significant increase in volume in shares of company
Board Meeting Intimation April 28, 2023
Large Entity Disclosure 24 Apr 2023
Reg 7(3) 11032023 11 Apr 2023
Trading Window Closure 31 March 2023
CEO Press Release
Outcome of the Board Meeting February 08, 2023
Schedule of Conference Call to discuss financial performance for quarter ended December 31, 2022
Certificate under Regulation 74(5)- January 12, 2023.
Trading Window Closure 30-12-2022.
November 09,2022 Corrigendum to the Outcome of Board Meeting
Buyback Public Announcement
Closure of Trading Window 30th September 2022.
Intimation of schedule of analyst & Institutional Investor Meeting- 22nd September 2022.
21st AGM Voting results.
21st AGM Proceedings.
Intimation of schedule of analyst & Institutional Investor Meeting- 8th September 2022.
INVESTOR MEETING -1st September 2022
Regulation 34 Annual report FY 21-22 intimation.
Newspaper advertisement of 21st AGM
Book Closure
Q1 FY22-23 Earning Call
Financial Results Q1 FY 22-23
Schedule of Conference Call to discuss financial performance for quarter ended June 30, 2022.
Virtual Meeting - Exchange Intimation
Trading Window Closure Q1
Investor Conference
Press Release
Annual Secretarial Compliance Report for the year ended March 31, 2022
Board Meeting Outcome 12052022
Press Release GMP
Initial Disclosure
Earnings Call
Investor meeting 30th March 2022
Investor meeting 31st March 2022
Investor meeting 17 Feb 2022
Intimation of Schedule of Analyst / Institutional Investor meetings
Investor meeting with the exchanges.
Reg 74(5) certificate
Closure of trading window
Investec conference
Closure of trading window